Risk factors for complications after partial splenic embolization for liver cirrhosis
β Scribed by H. Hayashi; T. Beppu; K. Okabe; T. Masuda; H. Okabe; H. Baba
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 118 KB
- Volume
- 95
- Category
- Article
- ISSN
- 0007-1323
- DOI
- 10.1002/bjs.6081
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Background
Partial splenic embolization (PSE) in patients with cirrhosis can achieve a prolonged increase in blood cell count. However, there is little information on the risk factors for complications after PSE for liver cirrhosis.
Methods
Seventy patients (41 men and 29 women) with cirrhosis-induced hypersplenism underwent PSE. Based on the ChildβPugh classification, 30, 35 and five patients had class A, B and C disease respectively. Risk factors for complications after PSE were examined retrospectively by logistic regression analysis.
Results
The mean splenic infarction rate was 77Β·1 per cent. Twelve patients (17 per cent) had complications following PSE. In univariable analysis, ChildβPugh class C, total bilirubin level of 1Β·4 mg/dl or more, serum albumin level of 2Β·8 g/dl or less and infarcted splenic volume of 540 ml or more were significantly associated with complications after PSE. In multivariable analysis, ChildβPugh class C (P = 0Β·012) and infarcted splenic volume of 540 ml or more (P = 0Β·031) were identified as risk factors, with an odds ratio of 22Β·92 and 5Β·01 respectively.
Conclusion
ChildβPugh class C and a large splenic infarction volume are risk factors for complications after PSE for liver cirrhosis.
π SIMILAR VOLUMES
Refractory ascites (RA) is a challenging complication after orthotopic liver transplantation. Its treatment consists of the removal of the precipitating factors. When the etiology is unknown, supportive treatment can be attempted. In severe cases, transjugular intrahepatic portosystemic shunts, port
Autoimmune hepatitis has been reported to recur after liver transplantation. The aim of our study was to evaluate the risk factors associated with recurrence of autoimmune hepatitis. Forty-six patients that underwent liver transplantation because of end-stage liver disease secondary to autoimmune he
Recurrent hepatitis C is a frequent complication after liver transplantation for hepatitis C virus-related cirrhosis, but risk factors related to its development remain ill defined. Twenty-three patients receiving a primary liver graft for hepatitis C virus-related cirrhosis and with an assessable b